Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 11.34
-0.06 (-0.53%)
Sep 11, 2026, 5:30 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 235.94 million as of September 11, 2026. Its market cap has increased by 32.66% in one year.
Market Cap
235.94M
Enterprise Value
244.58M
Revenue
17.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.34
ChartMarket Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 235.94M, a decrease of -23.66%. That is a compound annual growth rate of -1.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 235.94M | -50.44% |
| Dec 30, 2025 | 476.07M | 173.36% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.89B |
| Idorsia | 1.35B |
| Basilea Pharmaceutica AG | 804.70M |
| Santhera Pharmaceuticals Holding AG | 248.37M |
| BioVersys AG | 160.71M |
| Molecular Partners AG | 132.54M |
| Xlife Sciences AG | 83.82M |
| MindMaze Therapeutics Holding | 29.61M |